Global Pharmatech, Inc. (GBLP)
OTCMKTS
· Delayed Price · Currency is USD
0.0500
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
Global Pharmatech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|
Period Ending | Jun '08 Jun 30, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 |
| Net Income | -2.24 | -3.3 | -1.23 | 0.2 | 0.31 | 0.3 |
| Depreciation & Amortization | 0.49 | 0.42 | 0.54 | 0.53 | 0.42 | 0.31 |
| Loss (Gain) From Sale of Assets | 0.8 | 0.8 | - | - | - | - |
| Provision & Write-off of Bad Debts | 1.3 | 1.3 | 0.46 | - | - | - |
| Other Operating Activities | -1.01 | -0.15 | - | - | -0.63 | - |
| Change in Accounts Receivable | -0.4 | -0.5 | 0.66 | -1.11 | -0.15 | -0.69 |
| Change in Inventory | 0.18 | 0.2 | -0.34 | -0.05 | -0.46 | -0.56 |
| Change in Accounts Payable | 0.21 | 0.29 | -0.15 | 0.03 | 0.34 | 0.17 |
| Change in Unearned Revenue | - | - | - | - | - | 0.08 |
| Change in Income Taxes | -0.05 | 0.05 | 0.01 | -0.03 | -0.05 | 0.04 |
| Change in Other Net Operating Assets | 0.71 | 0.41 | 0.22 | -1.35 | 1.39 | -0.4 |
| Operating Cash Flow | 0.17 | -0.38 | 0.26 | -1.86 | 1.17 | -0.83 |
| Capital Expenditures | -0.13 | -0.19 | -0.41 | -0.36 | -0.98 | -0.56 |
| Sale of Property, Plant & Equipment | - | - | 0.03 | - | - | - |
| Sale (Purchase) of Intangibles | 0.01 | -0 | - | -0.02 | - | -0.15 |
| Other Investing Activities | -0.06 | -0.01 | - | - | - | - |
| Investing Cash Flow | -0.18 | -0.2 | -0.39 | -0.38 | -0.98 | -0.71 |
| Short-Term Debt Issued | - | - | 0.25 | - | - | 0.18 |
| Long-Term Debt Issued | - | - | - | 2.58 | - | - |
| Total Debt Issued | - | - | 0.25 | 2.58 | - | 0.18 |
| Short-Term Debt Repaid | - | - | - | -1.36 | -0.47 | - |
| Long-Term Debt Repaid | - | - | -0.05 | - | - | - |
| Total Debt Repaid | -0.02 | - | -0.05 | -1.36 | -0.47 | - |
| Net Debt Issued (Repaid) | -0.02 | - | 0.2 | 1.22 | -0.47 | 0.18 |
| Issuance of Common Stock | - | - | 4.63 | 1.26 | 0 | - |
| Other Financing Activities | -0.01 | 0.18 | - | 0.25 | 0.3 | 0.12 |
| Financing Cash Flow | -0.03 | 0.18 | 4.83 | 2.73 | -0.17 | 0.3 |
| Foreign Exchange Rate Adjustments | 0.48 | 0.27 | 0.17 | 0.01 | - | - |
| Net Cash Flow | 0.44 | -0.14 | 4.86 | 0.5 | 0.02 | -1.23 |
| Free Cash Flow | 0.04 | -0.57 | -0.15 | -2.22 | 0.19 | -1.38 |
| Free Cash Flow Margin | 1.39% | -20.33% | -7.20% | -72.08% | 12.23% | -80.44% |
| Free Cash Flow Per Share | 0.00 | -0.03 | -0.01 | -0.13 | 0.01 | -0.32 |
| Cash Interest Paid | 0.23 | 0.19 | 0.16 | 0.19 | 0.13 | 0.11 |
| Cash Income Tax Paid | - | - | 0.02 | 0.17 | 0.02 | - |
| Levered Free Cash Flow | 0.33 | -0.18 | -0.01 | -2.74 | - | - |
| Unlevered Free Cash Flow | 0.47 | -0.07 | 0.07 | -2.62 | - | - |
| Change in Working Capital | 0.66 | 0.44 | 0.4 | -2.52 | 1.07 | -1.35 |
Source: S&P Capital IQ. Standard template. Financial Sources.